Assessment parameters
| Correlation to total CD34 cells/kg yield . | Assessment variable . | P . |
|---|---|---|
| Positive correlation | Baseline CD34/µL | .003 |
| Preapheresis CD34/µL | <.001 | |
| WBC (109/L) | .01 | |
| Platelet count (109/L) | .03 | |
| Number of days HU held | .01 | |
| Negative correlation | Age | <.001 |
| Hospitalizations previous year | .01 | |
| Number of chronic pain medications | .002 | |
| No correlation | Sex | .11 |
| Hemoglobin (g/dL) | .94 | |
| ARC (103/µL) | .26 | |
| Pretransfusion HbS% | .82 | |
| Posttransfusion HbS% | .55 | |
| HbF% | .14 | |
| Lactate dehydrogenase (U/L) | .28 | |
| Aspartate aminotransferase (U/L) | .37 | |
| Total bilirubin (mg/dL) | .89 | |
| Alkaline phosphatase (U/L) | .63 | |
| C-reactive protein (mg/mL) | .92 |
| Correlation to total CD34 cells/kg yield . | Assessment variable . | P . |
|---|---|---|
| Positive correlation | Baseline CD34/µL | .003 |
| Preapheresis CD34/µL | <.001 | |
| WBC (109/L) | .01 | |
| Platelet count (109/L) | .03 | |
| Number of days HU held | .01 | |
| Negative correlation | Age | <.001 |
| Hospitalizations previous year | .01 | |
| Number of chronic pain medications | .002 | |
| No correlation | Sex | .11 |
| Hemoglobin (g/dL) | .94 | |
| ARC (103/µL) | .26 | |
| Pretransfusion HbS% | .82 | |
| Posttransfusion HbS% | .55 | |
| HbF% | .14 | |
| Lactate dehydrogenase (U/L) | .28 | |
| Aspartate aminotransferase (U/L) | .37 | |
| Total bilirubin (mg/dL) | .89 | |
| Alkaline phosphatase (U/L) | .63 | |
| C-reactive protein (mg/mL) | .92 |
Bold indicates P ≤ .05.